Identification of Oral Lesions Through an Autofluorescence System

Launched by FEDERICO II UNIVERSITY · Jul 10, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at a new method called autofluorescence to help doctors identify abnormal growths in the mouth, known as oral lesions. These can include conditions like oral leukoplakia and oral lichen planus, which may lead to oral cancer if not caught early. The trial will involve three clinicians with varying levels of experience using this technology to see how well it works in detecting these lesions. They will measure how accurately the system identifies the lesions and how often it correctly rules out healthy tissue.

To participate in this study, you need to be at least 18 years old, and both smokers and non-smokers are welcome. However, if you currently have cancer or a specific diagnosis related to oral tissue changes, you may not qualify. People who join the trial will help researchers understand the effectiveness of this detection system, and they can expect to undergo a screening process that assesses the health of their oral tissues. Overall, this research aims to improve early detection of oral diseases, potentially leading to better outcomes for patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male and female;
• • Age ≥ 18 years;
• • Non-smokers and smokers
• Exclusion Criteria:
• • Cancer patients;
• • Patients presenting a histological diagnosis of oral mucosal dysplasia/carcinoma.